CARDINAL HEALTHCARE: Drug Recall
Recall #D-0165-2024 · 01/26/2022
Class II: Risk
Recall Details
- Recall Number
- D-0165-2024
- Classification
- Class II
- Product Type
- Drug
- Recalling Firm
- CARDINAL HEALTHCARE
- Status
- Terminated
- Date Initiated
- 01/26/2022
- Location
- Dublin, OH, United States
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 3 units
Reason for Recall
CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.
Product Description
AMOXICILLIN for Oral Suspension USP, 400MG/5ML, 100ML (when reconstituted), Manufactured In Canada By: TEVA CANA LIMITED, Toronto, Canada M1B 2K9; Manufactured For: TEVA PHARMACEUTICALS USA, INC., North Wales, PA 19454. NDC: 0093-4161-73
Distribution Pattern
Nationwide USA
Other Recalls by CARDINAL HEALTHCARE
- Class II: Risk 01/26/2022
- Class II: Risk 01/26/2022
- Class II: Risk 01/26/2022
- Class II: Risk 01/26/2022
- Class II: Risk 01/26/2022
Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.